99 related articles for article (PubMed ID: 15161647)
1. Inhibition of amyloid A amyloidogenesis in vivo and in tissue culture by 4-deoxy analogues of peracetylated 2-acetamido-2-deoxy-alpha- and beta-d-glucose: implications for the treatment of various amyloidoses.
Kisilevsky R; Szarek WA; Ancsin JB; Elimova E; Marone S; Bhat S; Berkin A
Am J Pathol; 2004 Jun; 164(6):2127-37. PubMed ID: 15161647
[TBL] [Abstract][Full Text] [Related]
2. Potential Use of Anti-Inflammatory Synthetic Heparan Sulfate to Attenuate Liver Damage.
Arnold K; Liao YE; Liu J
Biomedicines; 2020 Nov; 8(11):. PubMed ID: 33207634
[TBL] [Abstract][Full Text] [Related]
3. Selective Inhibition of Heparan Sulphate and Not Chondroitin Sulphate Biosynthesis by a Small, Soluble Competitive Inhibitor.
Maciej-Hulme ML; Dubaissi E; Shao C; Zaia J; Amaya E; Flitsch SL; Merry CLR
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209670
[TBL] [Abstract][Full Text] [Related]
4. Critical Influence of Cosolutes and Surfaces on the Assembly of Serpin-Derived Amyloid Fibrils.
Risør MW; Juhl DW; Bjerring M; Mathiesen J; Enghild JJ; Nielsen NC; Otzen DE
Biophys J; 2017 Aug; 113(3):580-596. PubMed ID: 28793213
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of
Wasonga G; Tatara Y; Kakizaki I; Huang X
J Carbohydr Chem; 2013; 32(5-6):392-409. PubMed ID: 27099411
[TBL] [Abstract][Full Text] [Related]
6. Preclinical Validation of the Heparin-Reactive Peptide p5+14 as a Molecular Imaging Agent for Visceral Amyloidosis.
Wall JS; Martin EB; Richey T; Stuckey AC; Macy S; Wooliver C; Williams A; Foster JS; McWilliams-Koeppen P; Uberbacher E; Cheng X; Kennel SJ
Molecules; 2015 Apr; 20(5):7657-82. PubMed ID: 25923515
[TBL] [Abstract][Full Text] [Related]
7. A common sugar-nucleotide-mediated mechanism of inhibition of (glycosamino)glycan biosynthesis, as evidenced by 6F-GalNAc (Ac3).
van Wijk XM; Lawrence R; Thijssen VL; van den Broek SA; Troost R; van Scherpenzeel M; Naidu N; Oosterhof A; Griffioen AW; Lefeber DJ; van Delft FL; van Kuppevelt TH
FASEB J; 2015 Jul; 29(7):2993-3002. PubMed ID: 25868729
[TBL] [Abstract][Full Text] [Related]
8. The effect of glycosaminoglycans (GAGs) on amyloid aggregation and toxicity.
Iannuzzi C; Irace G; Sirangelo I
Molecules; 2015 Feb; 20(2):2510-28. PubMed ID: 25648594
[TBL] [Abstract][Full Text] [Related]
9. Sugar glues for broken neurons.
Swarup VP; Mencio CP; Hlady V; Kuberan B
Biomol Concepts; 2013 Jun; 4(3):233-57. PubMed ID: 25285176
[TBL] [Abstract][Full Text] [Related]
10. Divergent effect of glycosaminoglycans on the in vitro aggregation of serum amyloid A.
Aguilera JJ; Zhang F; Beaudet JM; Linhardt RJ; Colón W
Biochimie; 2014 Sep; 104():70-80. PubMed ID: 24878279
[TBL] [Abstract][Full Text] [Related]
11. Interfering with UDP-GlcNAc metabolism and heparan sulfate expression using a sugar analogue reduces angiogenesis.
van Wijk XM; Thijssen VL; Lawrence R; van den Broek SA; Dona M; Naidu N; Oosterhof A; van de Westerlo EM; Kusters LJ; Khaled Y; Jokela TA; Nowak-Sliwinska P; Kremer H; Stringer SE; Griffioen AW; van Wijk E; van Delft FL; van Kuppevelt TH
ACS Chem Biol; 2013 Oct; 8(10):2331-8. PubMed ID: 23972127
[TBL] [Abstract][Full Text] [Related]
12. Amyloid formation in heterogeneous environments: islet amyloid polypeptide glycosaminoglycan interactions.
Wang H; Cao P; Raleigh DP
J Mol Biol; 2013 Feb; 425(3):492-505. PubMed ID: 23154166
[TBL] [Abstract][Full Text] [Related]
13. Heparin induces harmless fibril formation in amyloidogenic W7FW14F apomyoglobin and amyloid aggregation in wild-type protein in vitro.
Vilasi S; Sarcina R; Maritato R; De Simone A; Irace G; Sirangelo I
PLoS One; 2011; 6(7):e22076. PubMed ID: 21779376
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress is induced by islet amyloid formation and time-dependently mediates amyloid-induced beta cell apoptosis.
Zraika S; Hull RL; Udayasankar J; Aston-Mourney K; Subramanian SL; Kisilevsky R; Szarek WA; Kahn SE
Diabetologia; 2009 Apr; 52(4):626-35. PubMed ID: 19148619
[TBL] [Abstract][Full Text] [Related]
15. Salts enhance both protein stability and amyloid formation of an immunoglobulin light chain.
Sikkink LA; Ramirez-Alvarado M
Biophys Chem; 2008 Jun; 135(1-3):25-31. PubMed ID: 18395318
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of glycosaminoglycan synthesis and protein glycosylation with WAS-406 and azaserine result in reduced islet amyloid formation in vitro.
Hull RL; Zraika S; Udayasankar J; Kisilevsky R; Szarek WA; Wight TN; Kahn SE
Am J Physiol Cell Physiol; 2007 Nov; 293(5):C1586-93. PubMed ID: 17804609
[TBL] [Abstract][Full Text] [Related]
17. Micro-imaging of amyloid in mice.
Wall JS; Paulus MJ; Gleason S; Gregor J; Solomon A; Kennel SJ
Methods Enzymol; 2006; 412():161-82. PubMed ID: 17046658
[TBL] [Abstract][Full Text] [Related]
18. The effects of sodium sulfate, glycosaminoglycans, and Congo red on the structure, stability, and amyloid formation of an immunoglobulin light-chain protein.
McLaughlin RW; De Stigter JK; Sikkink LA; Baden EM; Ramirez-Alvarado M
Protein Sci; 2006 Jul; 15(7):1710-22. PubMed ID: 16751605
[TBL] [Abstract][Full Text] [Related]
19. Heparin accelerates gelsolin amyloidogenesis.
Suk JY; Zhang F; Balch WE; Linhardt RJ; Kelly JW
Biochemistry; 2006 Feb; 45(7):2234-42. PubMed ID: 16475811
[TBL] [Abstract][Full Text] [Related]
20. Protein folding pathology in domestic animals.
Gruys E
J Zhejiang Univ Sci; 2004 Oct; 5(10):1226-38. PubMed ID: 15362194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
